[Treatment of visceral leishmaniasis or kala-azar (author's transl)].
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000967:Antimony Sodium Gluconate / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000517:prevention & control; D008536:Meglumine / Q000009:adverse effects / Q000627:therapeutic use; D010419:Pentamidine / Q000009:adverse effects / Q000627:therapeutic use
D010419:Pentamidine; D008536:Meglumine; D000666:Amphotericin B; D000967:Antimony Sodium Gluconate
Traitement des leishmanioses viscérales ou kala-azar.